Kiplinger’s Top 5 Stocks for Dad
Dads, you’re probably expecting a tie or a set of power tools this Father’s Day. If you have enough of those already (or even if you don’t), Kiplinger.com has a gift you’ll really appreciate: stock picks in companies that cater to your tastes. Kiplinger’s Top 5 Stocks for Dad are:
Eli Lilly (LLY) Men can appreciate this stock for its erectile-dysfunction drug Cialis (which accounts for 7% of total sales). But the case for investing in Lilly’s stock rests on a robust pipeline of new drugs. Among the drugs currently awaiting regulatory approval are Effient, a blood thinner that will compete directly with Plavix, as well as drugs for treating Alzheimer’s, cancer and neurological disorders are in various stages of development. The stock, which closed at $32.98, has fallen 18% in 2009. Still, analysts expect Lilly to earn $4.22 a share this year, up from $4.02 in 2008.
JoS. A. Bank Clothiers (JOSB) The purveyor of men’s suit and dress accessories has reacted to the recession strategy by marking down its wares severely. To conserve cash, the clothier has trimmed the number of new-store openings to just ten to 15 this year. In the first fiscal quarter, the retailer posted an 11% gain in revenues and a 17% jump in earnings. Same-store sales (sales at stores open for at least one year) rose 4.3%.
“5 Stocks Dad Will Love” is available in its entirety at http://kiplinger.com/columns/picks/archive/2009/pick0616.htm